Is Sermorelin FDA Approved? Status, Mechanism, and Safety

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub, our resource for evidence-based guidance on longevity protocols, peptide therapies, and the genetics behind aging-related decisions. Browse all Peptides & Longevity education for more.

The approval question around sermorelin is genuinely confusing because the answer has changed over time. Sermorelin was approved, then its brand product left the market, and the version most people encounter now arrives through a different channel entirely. Here is the full picture, along with how it works and the genetic terrain underneath.

The regulatory status, past and present

Sermorelin was originally FDA-approved in 1990 for diagnostic use and for pediatric growth hormone deficiency. The branded product was later discontinued in 2008. Today, compounded sermorelin from licensed 503A pharmacies is the form most patients access for adult longevity-protocol use. So the honest answer is layered: it holds a history of approval, but the modern longevity-protocol version is a compounded preparation rather than a branded, FDA-approved drug.

What "compounded" changes

Compounded products dispensed through licensed 503A pharmacies follow USP standards for sterility and potency, but they are not FDA-approved as branded products. That distinction is worth understanding before any protocol conversation, because it shapes what documentation, oversight, and expectations apply.

What sermorelin is

Sermorelin is a synthetic 29-amino-acid peptide that mirrors the active portion of human growth hormone-releasing hormone, known as GHRH 1-29. It prompts the pituitary to release growth hormone in a pulsatile, physiological pattern rather than a flat, continuous one. Because it works with the body's own release rhythm, it is often discussed as an upstream approach within the growth hormone axis.

How sermorelin works

Sermorelin acts on the growth hormone axis and IGF-1 signaling. Effects studied in this arena can touch aging-related biology, energy metabolism, and tissue repair, and they are mediated through specific receptor pathways rather than a single lever. The pharmacological mechanism is well described in peer-reviewed literature, while clinical effect sizes vary with indication, individual factors, and adherence.

Safety in context

Sermorelin has a documented safety profile in the clinical literature. Common side effects, serious warnings, and contraindications differ by compound and by patient, so your specific medical history belongs in a conversation with a prescribing provider rather than in a generic reference.

How PlexusDx approaches it

PlexusDx offers sermorelin through its Longevity Protocols; the Sermorelin product page carries the current formulation, dosing format, and pricing. What distinguishes the approach is the upstream genetic context that comes before any protocol decision.

The genetic variable

Variants in FOXO3, IGF1, and KLOTHO shape the baseline biology that sermorelin acts on, influencing the growth hormone axis and IGF-1 signaling every sermorelin protocol works through. These variants are pathway-level: they describe the metabolic and longevity terrain a clinician is prescribing into, and they never predict response to a specific compound. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including variants in FOXO3, IGF1, and KLOTHO — through 503A compounding pathways only, turning guesswork into an informed conversation with your provider.

Keep reading on PlexusDx: What Is GLP-1, GLP-1 Receptor Agonist, and GLP-1 Drugs.

Why the history still matters today

The 1990 approval and 2008 discontinuation are more than trivia. Together they explain why you will not find a branded, shelf-stocked sermorelin product the way you would for a currently marketed drug, and why compounded preparations became the practical route for adult longevity-protocol use. Understanding that lineage helps set realistic expectations about documentation and availability.

It also underscores why the compounding channel matters. A 503A pharmacy prepares the peptide to a prescriber's order under USP standards, a different framework from an FDA-approved branded product. Neither is automatically better; they are simply different regulatory pathways with different implications that are worth discussing with your provider before you begin.

For someone weighing sermorelin today, the takeaway is to plan around the compounded reality rather than expecting a branded product. That means a prescriber, a clinical evaluation, and a licensed 503A pharmacy, with expectations calibrated to what the clinical literature actually describes. The regulatory history simply explains how the current landscape came to look the way it does.

Frequently Asked Questions

Was sermorelin ever FDA-approved?

Yes. Sermorelin was FDA-approved in 1990 for diagnostic use and pediatric growth hormone deficiency, but the branded product was discontinued in 2008. The version most adults access for longevity protocols today is compounded through licensed 503A pharmacies, which is not the same as a branded, FDA-approved drug.

What kind of molecule is sermorelin?

Sermorelin is a synthetic 29-amino-acid peptide that mirrors the active portion of growth hormone-releasing hormone, GHRH 1-29. It stimulates the pituitary to release growth hormone in a pulsatile, physiological pattern. Its mechanism along the growth hormone axis is well documented in the peer-reviewed clinical literature.

Is compounded sermorelin safe?

Sermorelin has a documented safety profile, though common side effects, warnings, and contraindications vary by compound and patient. Compounded products from licensed 503A pharmacies follow USP standards for sterility and potency. Discuss your specific medical history with a prescribing provider before starting any protocol.

Does genetic testing predict how I will respond to sermorelin?

No. The Precision Peptide Genetic Test does not predict response to sermorelin or any compound. It analyzes pathway-level variants in FOXO3, IGF1, and KLOTHO that shape baseline growth hormone axis and IGF-1 biology, offering upstream context that applies across longevity-protocol decisions rather than a prediction.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.